Showing 1 - 20 results of 121 for search '"Immunotherapy methods"', query time: 1.31s Refine Results
1
2
3
4
5

Source: Members of Danish Multiple Sclerosis Group, Sellebjerg, F T, Magyari, M, Blinkenberg, M, Oturai, A B, Fredriksen, J L, Jensen, M B, Tørring, J, Pfleger, C C & Weglewski, A 2019, ' Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy ', Journal of Neurology, vol. 266, no. 2, pp. 306-315 . https://doi.org/10.1007/s00415-018-9126-y
Rasmussen, P V & Members of Danish Multiple Sclerosis Group 2019, ' Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy ', Journal of Neurology, vol. 266, no. 2, pp. 306-315 . https://doi.org/10.1007/s00415-018-9126-y
Chalmer, T A, Kalincik, T, Laursen, B, Sorensen, P S, Magyari, M, Members of Danish Multiple Sclerosis Group & Jensen, H B 2019, ' Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy ', Journal of Neurology, vol. 266, no. 2, pp. 306–315 . https://doi.org/10.1007/s00415-018-9126-y

File Description: application/pdf

6
7

Source: Peipp, M, Wesch, D, Oberg, H H, Lutz, S, Muskulus, A, van de Winkel, J G J, Parren, P W H I, Burger, R, Humpe, A, Kabelitz, D, Gramatzki, M & Kellner, C 2017, ' CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells ', Scandinavian Journal of Immunology, vol. 86, no. 4, pp. 196-206 . https://doi.org/10.1111/sji.12581

File Description: application/pdf

HTML Full Text     PDF Full Text
8
10
11
12
13

Source: Clinical and Experimental Immunology, 195(1), 1. Wiley-Blackwell
Clinical and Experimental Immunology

File Description: text/plain

14

Source: Immunity, Vol. 49, No 6 (2018) pp. 1148-1161.e7

15

Source: Nature communications, vol. 9, no. 1, pp. 1092
Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)
Nature Communications

File Description: application/pdf

16
17
18

Contributors: Massachusetts Institute of Technology. Department of Biology, Koch Institute for Integrative Cancer Research at MIT, Rickelt, Steffen, Hynes, Richard O.

Source: Immunity, Vol. 44, No 2 (2016) pp. 343-354
Elsevier

File Description: application/pdf

20

Contributors: Promovendi ODB, MUMC+: BC - Hematologie, Interne Geneeskunde, Radiotherapie, MUMC+: B&L Weefseltypering, MUMC+: B&L TI Staf, RS: GROW - Oncology, RS: GROW - R3 - Basic and Translational Cancer Biology, RS: GROW - R2 - Innovative Cancer Diagnostics & Therapy, Hematology laboratory, CCA - Innovative therapy, CCA - Quality of life

Source: Cancer Immunology, Immunotherapy
Cancer Immunology Immunotherapy, 64(8), 951-963. Springer
Cancer Immunology and Immunotherapy, 64(8), 951-63. Springer Science and Business Media Deutschland GmbH